Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

Crick COVID Serology Consortium, Edward J Carr, Mary Y Wu, Joshua Gahir, Ruth Harvey, Hermaleigh Townsley, Chris Bailey, Ashley S Fowler, Giulia Dowgier, Agnieszka Hobbs, Lou Herman, Martina Ragno, Murad Miah, Phillip Bawumia, Callie Smith, Mauro Miranda, Harriet V Mears, Lorin Adams, Emine Haptipoglu, Nicola O'ReillyScott Warchal, Chelsea Sawyer, Karen Ambrose, Gavin Kelly, Rupert Beale, Padmasayee Papineni, Tumena Corrah, Richard Gilson, Steve Gamblin, George Kassiotis, Vincenzo Libri, Emma C Wall*, et al

*Corresponding author for this work

Research output: Contribution to journalComment/debate (Academic Journal)

20 Citations (Scopus)

Abstract

[No abstract]
Original languageEnglish
Pages (from-to)781-784
Number of pages4
JournalThe Lancet. Infectious diseases
Volume23
Issue number7
DOIs
Publication statusPublished - 1 Jul 2023

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Ltd.

Keywords

  • Adult
  • Humans
  • Antibodies, Viral
  • SARS-CoV-2
  • Vaccines, Combined
  • COVID-19 Vaccines
  • Antibodies, Neutralizing
  • COVID-19/immunology

Fingerprint

Dive into the research topics of 'Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection'. Together they form a unique fingerprint.

Cite this